VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
45 hedge funds and large institutions have $26.6M invested in Viracta Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $36.6M → $26.6M (-$9.96M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
45
Holding in Top 10
2
Calls
$101K
Puts
$5K
Top Buyers
| 1 | +$3.26M | |
| 2 | +$3.24M | |
| 3 | +$1.72M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.15M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.02M |
Top Sellers
| 1 | -$7.25M | |
| 2 | -$1.19M | |
| 3 | -$863K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$386K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$208K |